Ecto-ATPase, a transmembrane enzyme chat catalyzes the hydrolysis of e
xtracellular ATP (ATP(e)) to ADP and inorganic phosphate, is expressed
upon cell activation. Ecto-ATPase is inhibited by non-hydrolyzable AT
P analogues, which are competitive inhibitors of the catalytic reactio
n, and the ATP analogue affinity label, 5'-p-(fluorosulfonyl)benzoyl a
denosine (5'-FSBA), which irreversibly inhibits the catalytic activity
. These nucleotide antagonists do not cross the cell membrane and are
specific for ecto-ATPase in T cells, B cells and NK cells. Inhibition
of ecto-ATPase by both reversible and irreversible nucleotide antagoni
sts results in the inhibition of antigen-induced cytokine secretion an
d cytolytic activity of T cells. Likewise, granule release and cytolyt
ic activity of NK cells as well as antibody secretion and spontaneous
proliferation by B-cell hybridomas are inhibited. Inhibition of ecto-A
TPase does not influence effector cell-target cell conjugate formation
, but acts, in part, by regulating che influx of extracellular calcium
that is necessary to maintain cellular activation. Thus, further eluc
idation of ecto-ATPase regulation and expression and its interaction w
ith intracellular signal transduction events will provide a basis for
understanding the role of the hydrolysis of ATP(e) by ecto-ATPase in l
ymphocyte effector function.